PATENT CLAIM ANALYSIS

Application Number: 16050029
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-03
Patent Classification: ["424", "468000"]

Abstract:
A pharmaceutical composition comprising Compound 1, (3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid), and at least one excipient selected from: a filler, a diluent, a disintegrant, a surfactant, a binder, a glidant and a lubricant, the composition being suitable for oral administration to a patient in need thereof to treat a CFTR mediated disease such as Cystic Fibrosis. Methods for treating a patient in need thereof include administering an oral pharmaceutical formulation of Compound 1 to the patient.

Claim (Index 68):
The tablet as claimed in  claim 56 , wherein the filler is selected from cellulose, modified cellulose, sodium carboxymethyl cellulose, ethyl cellulose hydroxymethyl cellulose, hydroxypropylcellulose, cellulose acetate, microcrystalline cellulose, dibasic calcium phosphate, sucrose, lactose, corn starch, potato starch, and any combination thereof.

Metadata:
- Claim Count in Document: 107.0
- Percentile: 95.0
- Lexical Diversity: 1.61538
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15001036', '14542396', '13081750', '13942617', '15035969']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7973903663869496
- 35 USC 102 Novelty (BERT): 0.6237343644447215
- Combined Prediction Score: 0.7800247661927268
- Mean Citation Score: 509.374952
- Max Citation Score: 591.507
- Similarity Product: 531.1324247698188

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test